Guselkumab tops adalimumab for psychiatric comorbidities in psoriasisOctober 31, 2017Psoriatic Arthritis
Psoriasis patients face higher risk of alcohol-related death – but lower suicide riskOctober 27, 2017Psoriatic Arthritis
Biosimilars poised to save $54 billion over the next decadeOctober 25, 2017Psoriatic ArthritisAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesBusiness of Medicine
Golimumab earns new FDA approvalsOctober 24, 2017Psoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Psoriasis: Biologics bring potential for long-term remission off treatmentOctober 22, 2017Psoriatic Arthritis
High ‘nocebo’ effect observed when patients knowingly switch to a biosimilarOctober 18, 2017Psoriatic ArthritisSpondyloarthropathiesRheumatoid ArthritisAnkylosing spondylitis
Pediatric psoriasis carries sharply increased risk of selected autoimmune comorbiditiesOctober 14, 2017Psoriatic Arthritis
TNF inhibitors associated with fewer side effects than methotrexate in children with psoriasisSeptember 30, 2017Psoriatic Arthritis
